Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) | SPD-M180

(No reviews yet) Write a Review
SKU:
SPD-M180
Epitope:
Spike RBD
Isotype:
Human IgG1
Source:
Human
€460.00 - €2,750.00
Frequently bought together:

Description

Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) | SPD-M180 | Acro Biosystems | SARS-CoV-2 Neutralizing Antibodies

Description
 
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM128) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.98 μg/mL using SARS-CoV-2 Inhibitor Screening Kit (Cat. No. EP-105).Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.
 
Isotype
 
Human IgG1/kappa
 
Specificity
 
This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. Cross-reactivity with RBD of other coronaviruses has not been tested.
 
Purity

>95% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20 to -70°C for 12 months in lyophilized state from date of receipt;

-70°C for 3 months under sterile conditions after reconstitution.

View AllClose

Related Products